News - Follistim AQ Vial Now Available in 75 IU and 150 IU Presentations

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Pregnancy

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Pregnancy

	TopAbstracts in Pregnancy 11/03/2009 - (DGNews)
	Study Examines Associations Between Antibiotic Use During Pregnancy, Birth Defects - (DGNews)
	Pregnant Women Show Strong Immune Response to One Dose of H1N1 Vaccine - (DGNews)
	Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study - (BMJ)
	Vaccinated Pregnant Women Protect Their Unborn From Acquiring Seasonal Influenza: Presented at IDSA - (DGDispatch)

News archive

Recent webcasts/CME - Pregnancy

Improving Epilepsy Management Throughout the Disease Continuum

	Pregnancy Planning and Preconception Health Care for HIV-Infected Individuals and Couples
	Luteal Support in Reproduction
	Managing the Critically Ill Pregnant Patient
	HIV Testing Update

Webcasts/CME archive

Recent cases - Pregnancy

	There May be a Link Between Intrahepatic Cholestasis of Pregnancy and Familial Combined Hyperlipidaemia: A Case Report
	Recurrent Spontaneous Pneumothorax During Pregnancy: A Case Report
	Damage Control Surgery by Keeping the Abdomen Open During Pregnancy: Favorable Outcome, A Case Report
	A Life Threatening Uterine Inversion and Massive Post Partum Hemorrhage Caused by Placenta Accrete During Caesarean Section in a Primigravida: A Case Report
	HELLP Syndrome, Multiple Liver Infarctions, and Intrauterine Fetal Death in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Cases archive

my personal edition > pregnancy > news

E-Mail this DGNews to a colleague

DGNews

Follistim AQ Vial Now Available in 75 IU and 150 IU Presentations

Offers Patients More Flexibility With Fertility Treatment

ROSELAND, NJ -- October 5, 2005 -- Organon Pharmaceuticals Inc USA announces today the availability of Follistim(R) AQ (follitropin beta injection) 75 IU and 150 IU presentations in single-use 0.5 mL vials in pre-mixed solution, therefore eliminating reconstitution.

Follistim(R) AQ is for subcutaneous and intramuscular injection used by patients undergoing assisted reproductive technology procedures, such as IVF and for the induction of ovulation to achieve pregnancy.

"Organon is pleased to provide patients and physicians a full range of fertility medications that can be tailored to meet individual needs. The addition of the Follistim(R) AQ vial in 75 IU and 150 IU presentations complements our existing fertility product portfolio of the Follistim(R) AQ Cartridge in 300 IU, 600 IU and 900 IU strengths which are designed to be used with the Follistim Pen(R)," said Michael Novinski, President, Organon Pharmaceuticals USA Inc. "Through our brands and supporting web sites, Organon is committed to providing integrated programs that meet patient's needs."

Safety Information for Follistim(R) AQ Cartridge and Follistim(R) AQ Vial

-- Follistim(R) AQ Cartridge/Vial, like all gonadotropins, is a potent substance capable of causing mild to severe side effects including OHSS, with or without pulmonary or vascular complications.

-- Follistim(R) AQ Cartridge/Vial, should be prescribed only by physicians who are experienced in infertility treatment and physicians should advise their patients of treatment risks, including OHSS and multiple births.

Safety Information for Follistim(R) AQ Cartridge

-- Follistim(R) AQ Cartridge administered with Follistim Pen(R) delivers on average an 18% higher amount of follitropin beta compared to lyophilized preparations administered with a conventional syringe and needle. A lower dose should be considered when using Follistim(R) AQ Cartridge.

SOURCE: Organon Pharmaceuticals Inc USA

E-Mail this DGNews to a colleague To print, use this version